// App-Quantinova.ai

TCT515 : Multi-Center, Post-marketing Evaluation of the Elixir DESolve Novolimus Eluting Bioresorbable Coronary Stent System: 6-month Results from the DESolve PMCF Study

Researchers

Presenter

  • Holger Nef

Principal Investigators

  • Karl-Eugen Hauptmann

  • Azeem Latib

  • Ricardo A. Costa

  • Lynn Morrison

  • Sara Toyloy

  • Lynn Vandertie

  • Antonio Colombo

Medical Centers

  • Krankenhaus der Barmherzigen Brueder, Trier, Trier, Germany

  • Justus-Liebig University of Giessen, Giessen, Germany

  • Hospital San Raffaele, Milan, Italy

  • ICU, Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil

  • EMO GVM Centro Cuore Columbus/San Raffaele Hospital, Milan, Italy

  • Medical Device Consultancies, Christ Church, New Zealand

  • elixir medical corporation, Sunnyvale, CA

Locations

  • Brazil

  • Italy

  • Germany

  • United States

  • New Zealand

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Coronary artery lesions

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved